Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
2
33%
Ph phase_4
3
50%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Other(1)

Detailed Status

Completed5
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 43 (50.0%)
N/A2 (33.3%)

Trials by Status

completed583%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

NCT05276531
completednot_applicable

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support

NCT03734770
completedphase_4

Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone

NCT02567552
unknownphase_3

Endometrial Polyps Regression With Progesterone Therapy

NCT03309709
completedphase_4

Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients

NCT02363127
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05276531Not Applicable

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

Completed
NCT03734770Not Applicable

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support

Completed
NCT02567552Phase 4

Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone

Completed
NCT03309709Phase 3

Endometrial Polyps Regression With Progesterone Therapy

Unknown
NCT02363127Phase 4

Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients

Completed
NCT02316626Phase 4

Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6